CORCEPT THERAPEUTICS INC Debt Securities, Available-for-sale, Noncurrent
CORCEPT THERAPEUTICS INC (CORT) had Debt Securities, Available-for-sale, Noncurrent of $4.95 million as of 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent · last filed 2023-02-28
- 2022-12-31: Debt Securities, Available-for-sale, Noncurrent $4.95M.
- 2021-12-31: Debt Securities, Available-for-sale, Noncurrent $112.28M.
- 2020-12-31: Debt Securities, Available-for-sale, Noncurrent $36.20M.
- 2019-12-31: Debt Securities, Available-for-sale, Noncurrent $39.35M.
| Period end | Debt Securities, Available-for-sale, Noncurrent |
|---|---|
| 2022-12-31 | $4.95M 10-K · filed 2023-02-28 |
| 2021-12-31 | $112.28M 10-K · filed 2023-02-28 |
| 2020-12-31 | $36.20M 10-K · filed 2022-02-15 |
| 2019-12-31 | $39.35M 10-K · filed 2021-02-23 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-24 |
| 2017-12-31 | $15.28M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |